📰 Patrick Kroupa News
Patrick Kroupa News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Patrick Kroupa. Real-time updates on events, politics, business and more.
June 30, 2023
Activists Howard and Norma Lotsof devote their lives to the study of ibogaine to help people with addiction and mental illness. Director Lucy Walker humanizes suffering.
April 28, 2021
Microdose Psychedelic Insights: April Psychedelic Capital Investigates Clinical Trials & Real World Evidence & Going Mainstream: Mass Adoption Clinical Trials & RWE and 1:30 PM: Intro 1:45 PM: BETTERLIFE PHARMA INC. (CSE: BETR) Featuring Patrick Kroupa, Ahmad Doroudian, Justin Kirkland 2:15 PM: Clinical Trials & RWE Featuring Henri Sant-Cassia, Malcolm Barratt-Johnson, Matthew W. Johnson 2:45 PM: NanoPsy 3:15 PM: Going Mainstream: Mass Adoption Featuring Richard Skaife, Ronan Levy, Kathry...
December 23, 2020
Press release content from Globe Newswire. The AP news staff was not involved in its creation. BetterLife Welcomes Psychedelic Industry Leaders to the Senior Management Team BetterLife PharmaDecember 23, 2020 GMT VANCOUVER, Dec. 22, 2020 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) CSE: BETR / OTCQB: BETRF / FRA: NPAU) an emerging biotech company, is pleased to announce that Patrick Kroupa and Justin Kirkland, two industry leaders in psychedelic therapeutic...
December 19, 2020
BetterLife’s Recent Acquisition: Taking LSD from Experimental to a Major Therapeutic Application BetterLife’s Recent Acquisition: Taking LSD from Experimental to a Major Therapeutic Application VANCOUVER, Dec. 14, 2020 — BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech focused on the development and commercialization of cutting edge treatments, today announced the value proposition of its acquisition of Transcend Bi...
December 15, 2020
Share: VANCOUVER, Dec. 14, 2020 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE:BETR, OTCQB:BETRF), an emerging biotech focused on the development and commercialization of cutting edge treatments, today announced the value proposition of its acquisition of Transcend Biodynamics, LLCs ("Transcend") manufacturing patent "Process of synthesizing 2-Bromo-LSD." While the medicalization of psychedelics is evolving and gaining momentum at an extraordinary pace, such...